(19)
(11) EP 4 087 618 A1

(12)

(43) Date of publication:
16.11.2022 Bulletin 2022/46

(21) Application number: 21738525.1

(22) Date of filing: 07.01.2021
(51) International Patent Classification (IPC): 
A61K 48/00(2006.01)
A61K 39/395(2006.01)
A61K 45/00(2006.01)
C12N 5/16(2006.01)
C12N 5/071(2010.01)
A61K 39/00(2006.01)
C12N 15/00(2006.01)
C07H 21/04(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/2875; C07K 2317/622; A61K 39/0011; A61K 2039/5156; C12N 2510/00; A61P 35/00; A61P 25/00; A61P 25/28; C07K 14/7051; C07K 2319/03; A61K 45/06; C12N 2501/515; C12N 2501/599; C12N 5/0646; A61K 35/17; A01K 2267/0331; A01K 2227/105; A01K 2207/12; C07K 16/30
(86) International application number:
PCT/US2021/012510
(87) International publication number:
WO 2021/142127 (15.07.2021 Gazette 2021/28)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 08.01.2020 US 202062958563 P

(71) Applicant: Board of Regents, The University of Texas System
Austin, TX 78701 (US)

(72) Inventor:
  • REZVANI, Katy
    Houston, Texas 77030 (US)

(74) Representative: J A Kemp LLP 
80 Turnmill Street
London EC1M 5QU
London EC1M 5QU (GB)

   


(54) A METHOD OF ENGINEERING NATURAL KILLER CELLS TO TARGET CD70-POSITIVE TUMORS